In 2023, the global Lipid Nanoparticles Market sales is anticipated to be worth US$ 887.2 million. Due to increased dietary supplement usage and rising health concerns about dietary supplements as a result of Covid-19, the market is expected to rise at a CAGR of 13.6% between 2023 and 2033, reaching approximately US$ 3,175.5 million by 2033.
The rapid increase in population in regions such as Asia Pacific, Europe, and North America is expected to contribute to the demand for products such as pharmaceuticals and healthcare, dietary supplements, functional food, functional beverages, cosmetics and personal care, and others. Lipids’ high omega 3 and omega 6 concentration is the primary reason for their extensive application in food and beverage products.
Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15992
Rising worldwide prices for fatty acids and other raw materials, which fluctuate as a result of COVID-19 and the current European geopolitical crisis, are limiting global market growth. Furthermore, market participants are focusing on R&D and making new breakthroughs in Lipid Nanoparticles technology, which is projected to provide lucrative prospects in the near future.
Pharmaceutical lipid sales are projected to be driven by factors such as rising demand for medicines due to the high frequency of cancer and chronic diseases, as well as a growing emphasis on physical well-being over the analysed period. Pharmaceutical excipients make lipids perform better, such as having a longer shelf life, and increase formulation efficacy. Furthermore, increased demand in emerging nations is propelling domestic drug production, which is fuelling market sales.
Advances in the composition of lipid nanoparticles for in-vivo systemic mRNA dispersion are also creating appealing industry potential. To address specific medical conditions, the major manufacturers in the lipid nanoparticles market are focused on developing lipid nanoparticle (LNP)-based therapeutics. Furthermore, they are focusing on establishing new lipid production facilities through agreements with government agencies.
The major players are heavily investing in product development activities, and their approach to growing the business through product launches and acquisitions is projected to drive the worldwide pharmaceutical lipids market’s growth in the coming years.
For any queries linked with the report, ask an analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-15992
Key Takeaways from the Market Study
- The global lipid nanoparticles market is expected to be valued US$ 781.0 million by the end of 2022.
- Market demand expanded at a 6.2% CAGR from 2018 to 2022.
- With a 45% market share, the Solid Lipid Nanoparticles market category accounts for the majority of the market.
- The Pharmaceutical & Biotechnology category dominates the market by End-User with a 43% market share.
- Between 2023 and 2033, sales of lipid nanoparticles are expected to expand at a CAGR of 13.6%.
- The market for Lipid Nanoparticles is expected to be worth US$ 3,175.5 million by 2033.
Leading manufacturers are focused on implementing technological advancements to reduce their drug development and manufacturing costs. This, in turn is expected to boost the growth of the Lipid Nanoparticles Market during the forecast period, remarks an FMI analyst.
Competitive Landscape
Prominent players in the Lipid Nanoparticles market are Merck KGaA, Evonik Industries AG, Gattefossé, Precision NanoSystems, IOI Oleo GmbH, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemicals Co. Ltd., Lipoid GmbH, Cargill, Incorporated, BASF SE, Archer Daniels Midland Company, Koninklijke DSM N.V., Kerry Group plc., Nordic Naturals, Inc., Clover Corporation, Croda International plc., Lipoid Kosmetik AG, and Omega Protein Corporation, among others.
Recent Developments:
- In October 2022, Polypeptide Therapeutic Solutions (PTS), key player in the manufacturing and development of polyamino-acid based delivery systems expanded its drug delivery capabilities including novel nanoparticle formulation and functional lipid excipients.
- In September 2022, National Institute of Allergy and Infectious Diseases awarded USD 13.8 million contract to the University of California for conducting immune profiling of lipid nanoparticles to study their role in increasing vaccine protective responses.
Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market@ https://www.futuremarketinsights.com/checkout/15992
Key Segments Covered in the Lipid Nanoparticles Industry Analysis
Lipid Nanoparticles Market by Type:
- Solid Lipid Nanoparticles (SLNs)
- Nanostructured Lipid Carriers (NLCs)
- Others
Lipid Nanoparticles Market by Application:
- Therapeutics
- Research
Lipid Nanoparticles Market by End-User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
